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ABSTRACT
Introduction Despite early adoption of the WHO 
guidelines to deliver lifelong antiretroviral (ARV) regimen 
to pregnant women on HIV diagnosis, the HIV prevention 
of mother to child transmission programme in Papua New 
Guinea remains suboptimal. An unacceptable number of 
babies are infected with HIV and mothers not retained in 
treatment. This study aimed to describe the characteristics 
of this programme and to investigate the factors 
associated with programme performance outcomes.
Methods We conducted a retrospective analysis of clinical 
records of HIV- positive pregnant women at two hospitals 
providing prevention of mother to child transmission 
services. All women enrolled in the prevention of mother 
to child transmission programme during the study period 
(June 2012–June 2015) were eligible for inclusion. Using 
logistic regression, we examined the factors associated 
with maternal loss to follow- up (LTFU) before birth and 
before infant registration in a paediatric ARV programme.
Results 763 of women had records eligible for inclusion. 
Demographic and clinical differences existed between 
women at the two sites. Almost half (45.1%) of the 
women knew their HIV- positive status prior to the current 
pregnancy. Multivariate analysis showed that women 
more likely to be LTFU by the time of birth were younger 
(adjusted OR (AOR)=2.92, 95% CI 1.16 to 7.63), were 
newly diagnosed with HIV in the current/most recent 
pregnancy (AOR=3.50, 95% CI 1.62 to 7.59) and were in 
an HIV serodiscordant relationship (AOR=2.94, 95% CI 
1.11 to 7.84). Factors associated with maternal LTFU 
before infant registration included being primipara at 
the time of enrolment (AOR=3.13, 95% CI 1.44 to 6.80) 
and being newly diagnosed in that current/most recent 
pregnancy (AOR=2.49, 95% CI 1.31 to 4.73). 6.6% (50 of 
763) of exposed infants had a positive HIV DNA test.
Conclusions Our study highlighted predictors of LTFU 
among women. Understanding these correlates at different 
stages of the programme offers important insights for 
targets and timing of greater support for retention in care.
INTRODUCTION 
Maternal early initiation and adherence to 
antiretroviral therapy (ART) during preg-
nancy and breast feeding and prophylactic 
administration of antiretrovirals (ARV) to 
infants exposed to HIV can reduce the risk 
of transmission to newborns from 30%–45% 
to less than 5%.1–3 Through a combination of 
advancements in medicines, political commit-
ment, multilateral funding and a dedicated 
Strengths and limitations of this study 
 ► This study used real- world data from the national 
HIV prevention of mother to child transmission pro-
gramme in Papua New Guinea (PNG), providing data 
that reflect programme delivery in a routine setting.
 ► The study included over 700 clinical records, com-
prising the largest and most systematic evaluation 
of prevention of mother to child transmission pro-
grammes in PNG.
 ► The retrospective nature of the study made it reliant 
on the quality of data that had been collected, which 
in many cases were incomplete.
 ► Missing data limited the choice of data analysis 
approaches.
 ► Despite data limitations, this study provides import-
ant insights into the prevention of mother to child 
transmission programmes in PNG, and findings 
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health workforce, many countries have now eliminated 
mother to child transmission of HIV.4 5 Many settings have 
made significant progress in the implementation of the 
WHO- recommended Option B+ regimen, whereby all 
pregnant and breastfeeding women living with HIV are 
offered lifelong ART on diagnosis.6 However, many coun-
tries which have adopted Option B+, including Papua 
New Guinea (PNG), continue to struggle in providing 
effective prevention of mother to child transmission 
programmes and in retaining mothers and infants in life-
long care and treatment.7–9
Supporting maternal adherence to ART and retaining 
mothers and infants in these treatment programmes 
are essential components in preventing mother to 
child transmission of HIV. Factors contributing to 
lower adherence and greater loss to follow- up (LTFU) 
from prevention of mother to child transmission 
programmes include concerns with lifelong treatment, 
inadequate counselling, lack of male partner involve-
ment and support, fear of disclosure, knowing someone 
who has had a negative experience, and distance to the 
health facility.10–15 Conversely, good- quality HIV post- 
test counselling, support from partners and family, 
belief in ART efficacy and being aware of the improved 
survival of other people have been reported as facili-
tators to initiation of ART, adherence and reduced 
LTFU from prevention of mother to child transmission 
programmes.11 12 14–16
PNG is an independent Western Pacific Island nation 
of more than eight million people living a largely subsis-
tence livelihood in geographically challenging terrain. 
Roads poorly connect major centres, and where roads 
exist landslides, tribal fighting and lawlessness often 
restrict reliable and safe travel routes. The overall adult 
HIV prevalence (15–49 years) is 0.8%,17 higher in urban 
areas, and substantially greater among key populations 
of female sex workers, men who have sex with men and 
transgender women.18–20 Consistent with WHO recom-
mendations, PNG’s HIV treatment guidelines follow 
a test- and- treat model, including lifelong treatment 
for pregnant and breastfeeding women.21 Despite the 
progressive approach, it is estimated that only half (55%; 
26 400 of 48 000) of people living with HIV were receiving 
ART in 2017, and of the estimated 1700 pregnant women 
living with HIV only 41% received ART.22 The need for 
improvements in the prevention of mother to child 
transmission programmes is further highlighted by the 
fact that the number of babies born with HIV doubled 
between 2017 and 2018.23 What remains unknown is 
where and for which subpopulations the mother to 
child transmission programme is failing. Answers from 
national programmes could offer insight on where to 
target interventions to ensure women are not LTFU 
and to refocus and galvanise efforts to reduce neonatal 
infections to achieve the goal of eliminating mother to 
child transmission. We conducted a retrospective clinical 
audit at two antenatal clinics (ANC) in Goroka and Port 
Moresby in PNG to describe prevention of mother to 
child transmission programme characteristics and inves-




The two sites were selected as they were both in high- 
burden HIV provinces, were the longest running sites 
for prevention of mother to child transmission in the 
country, and were well supported through donor funding 
and non- governmental organisations, such as the Clinton 
Health Access Initiative. Port Moresby is the national 
capital city, on the southern coast of the country, and is a 
melting pot of people from across the country. It is one of 
only three cities in the country. Goroka is a town and the 
provincial capital of the Eastern Highlands Province, in 
the lower highlands region of the country. The geograph-
ical, sociocultural and economic contexts of these two 
sites are diverse. Unlike Port Moresby, Goroka is much 
smaller and people access the town from across the prov-
ince, travelling by foot and road. Travel between these 
two sites is only possible by air. HIV testing is available at 
numerous ANC clinics in each province; however, there 
is only one prevention of mother to child transmission 
clinic in each province.
The implementation model for the prevention of 
mother to child transmission programme differed 
between the two sites. In Port Moresby, prevention of 
mother to child transmission services were integrated in 
antenatal, delivery and postnatal care services for the first 
6 weeks. After the 6- week postnatal period, HIV- exposed 
infants were referred for enrolment in the paediatric 
HIV clinic for ongoing HIV prophylaxis, confirmatory 
HIV testing and treatment as required, while mothers 
were referred to the adult ART outpatient clinic. The 
adult and paediatric HIV clinics were not co- located and 
operated on different days, and clinical records were not 
linked manually or electronically. In Goroka, prevention 
of mother to child transmission services were integrated 
in antenatal, delivery and postnatal care, and the mother- 
infant pair is cared for by the same clinical team until the 
confirmatory HIV test for the infant was conducted at 18 
months. Despite its co- location infants were still enrolled 
in the paediatric HIV clinic at 6 weeks. At 18 months after 
birth, the mother was transferred (back) to the adult 
ART clinic, while the HIV- infected infant/s remained in 
the clinic for ongoing clinical care and management. All 
healthcare was provided by staff who were employed as 
government healthcare workers or were supported and 
funded by the Clinton Health Access Initiative, funded by 
the Australian government.
Study participants and procedures
The clinical audit used a ‘capture all’ approach, docu-
menting all women with HIV enrolled in the prevention 
of mother to child transmission programme for the 3- year 
time period spanning June 2012 (when Option B+ was 
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formally adopted in PNG) until June 2015. Data sources 
included paper- based antenatal records of HIV- positive 
women and their infants’ medical records at either the 
same prevention of mother to child transmission clinic 
(Goroka) or the paediatric HIV clinic elsewhere in the 
hospital (Port Moresby).
For all available records, two research midwives manu-
ally extracted data related to patient demographics, preg-
nancy care, HIV and other sexually transmitted infection 
testing, prevention of mother to child transmission enrol-
ment, ART initiation and clinic appointments, and these 
were recorded on preprinted study clinical research 
forms. Infants’ HIV DNA test results were obtained from 
infant records. Infant records in Goroka were physically 
co- located with the mothers. In Port Moresby, mother- 
infant pairs were linked manually by extracting the name 
of the mother, the birth date of the infant on her ANC 
record, and if recorded the sex of the newborn. Staff at 
the paediatric HIV clinic then identified infant records to 
link the mother- infant pairs.
Research midwives cross- checked each other’s 
completed data forms to ensure all forms were completed 
as accurately as possible. After reviewing each form for 
validity and completeness, de- identified data were double- 
entered into a purposely developed study database and 
stored on a password- protected computer at the Papua 
New Guinea Institute of Medical Research. All electronic 
data were merged into a single study database and anal-
ysed using STATA V.13.1.
Study measures and analysis
At enrolment into the prevention of mother to child 
transmission programme, sociodemographic, obstetric 
and HIV- related characteristics were recorded and labo-
ratory assessments conducted. In our analysis we only 
included the first pregnancy when assessing maternal 
characteristics and outcomes. However, for infant char-
acteristics and outcomes, all live births were included. 
LTFU was measured and defined at two timepoints. First, 
pregnant women enrolled in the prevention of mother to 
child transmission programme were categorised as ‘lost 
to follow- up before delivery’ if they did not return to the 
health facility for delivery, and could include scheduled 
antenatal prevention of mother to child transmission 
visits. Second, pregnant enrolled women in the preven-
tion of mother to child transmission programme were 
defined as ‘lost to follow- up before infant registration’ 
if they did not register the newborn child at the respec-
tive clinics for prevention of mother to child transmis-
sion services and were lost from the programme either 
during antenatal, peripartum or early postnatal services. 
Although the study sponsor originally sought to have the 
audit measure maternal LTFU at 2 years after lifetime 
ART initiation in the prevention of mother to child trans-
mission programme (Option B+), this was not possible. 
In PNG, paper- based adult ART records were used and 
there was no system that linked women in prevention 
from mother to child transmission programmes to adult 
ART service records. At the time the audit was under-
taken, only two ART sites in Port Moresby were using an 
electronic database, which was manually updated into 
a national database by staff at the National Department 
of Health every few months. Enrolment of a child into 
paediatric HIV programmes shows ongoing engagement 
in HIV care. The fact that so many women did not enrol 
their children in these clinics shows disengagement. Like 
prevention of mother to child transmission programmes, 
there is only one paediatric HIV clinic in each province.
Descriptive analyses were conducted to describe the 
women enrolled in the prevention of mother to child 
transmission programmes at the sites and the HIV 
outcomes of their infants. χ2 tests, two- sample t- tests and 
Wilcoxon rank- sum tests were performed to examine 
differences in sociodemographic and other behavioural 
characteristics of women and infants in the sites. Multivar-
iate logistic regression analysis was undertaken to investi-
gate factors associated with maternal LTFU before birth 
and the mean time before the infant was registered in 
a paediatric ART programme. Based on findings from 
previous research24 and data available from this study, we 
selected variables that might influence the outcome of 
interest (maternal LTFU) to be included in the predic-
tive models. For the analysis of factors associated with 
maternal LTFU before birth, we used Firth’s logistic 
regression25 26 to account for bias due to rare event data, 
which are known to produce substantial bias estimates 
with conventional logistic regression.27 Assumption of 
rare event data was made based on few outcome events 
per variable (EPV) guideline with at least five EPV in 
models used for confounding adjustment.28 Infant HIV 
testing and results were quantified and described.
Ethical considerations
This was a retrospective cohort study and women were 
no longer attending the ANC. Consent from the partici-
pating hospitals was granted to access clinical records on 
the condition that no identifiable information, including 
names, was recorded on the clinical research forms.
Patient and public involvement
We did not invite patient and public involvement in the 
design of the study due to the nature of the study, being 
a retrospective clinical audit commissioned by UNICEF. 
All study results were disseminated to stakeholders at the 
conclusion of the study.
RESULTS
Description of sample set
A total of 849 cases were identified and registered into the 
prevention of mother to child transmission programme 
across the two sites (figures 1 and 2). Eight women and 
their records were excluded as they described women who 
were not pregnant (n=4), not HIV- infected (n=3) or had 
been diagnosed through a sick child (n=1). Of the 841 
remaining eligible pregnancies, 39 (4.6%) had missing 
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ANC records, 11 records (1.3%) described women who 
had twins, and 28 women (3.3%) had two pregnancies in 
the study period and were therefore enrolled twice in the 
prevention of mother to child transmission programme in 
the period under investigation. The final analysed sample 
therefore described 763 eligible HIV- positive pregnant 
women (figure 1), which resulted in 763 live births and 
30 stillbirths (figure 2). Not all records were complete. 
PNG uses paper- based records systems for prevention 
of mother to child transmission and paediatric HIV 
programmes that are not linked by a unique identifica-
tion code or any other identifier. The challenges associ-
ated with linking mother- infant pairs resulted in some 
data not being available. The changing denominators in 
the table indicate where data were missing.
Sociodemographic characteristics of enrolled women
One- third of the analysed records were from women regis-
tered at the Goroka prevention of mother to child trans-
mission site and the other two- thirds from Port Moresby. 
The mean age of participants was 25 years at both sites. 
A greater proportion of women in Port Moresby were 
married (77.3% compared with 51.4%, p<0.001), had 
received any formal education (92.2% compared with 
72.4%, p<0.001) and were employed in the formal sector 
(21.1% compared with 1.7%, p<0.001) than women in 
Goroka (table 1).
HIV and ART characteristics of enrolled women
Table 1 also details the HIV and ART characteristics of 
the population. Just over half (54.9%) of the cohort were 
newly diagnosed with HIV in their current pregnancy, with 
this proportion being greater in Port Moresby (57.9%) 
compared with Goroka (49.0%, p=0.020; table 2). In 
Goroka, women who already knew they were HIV- positive 
enrolled in the prevention of mother to child trans-
mission programme earlier than those in Port Moresby 
(mean gestational weeks at enrolment 22.5 for Goroka 
and 26.1 for Port Moresby, p<0.001); however, timing of 
enrolment was not statistically different across the two 
sites for newly diagnosed women (table 2).
The median CD4 T cell count at enrolment into the 
programme was 327 cells/µL in Goroka, compared with 
273 cells/µL in Port Moresby (p=0.005). More than 10% 
of all women were positive for antibodies to hepatitis 
B virus (13.7% in Goroka and 12.3% in Port Moresby, 
p=0.61).
Most (99.7%) of the women at both sites were receiving 
ART (table 2). Among those who already knew they 
were HIV- positive, most (91.3%) were taking ongoing 
treatment, with 8.7% recommencing treatment during 
the current pregnancy. While 100% of newly diagnosed 
women in Port Moresby were receiving ART, this was 
significantly lower among women in Goroka (92.4%, 
p<0.001).
Among women who were newly diagnosed, ART initi-
ation was slower in Goroka with a median time between 
diagnosis and ART initiation of 14 days compared with 
5 days in Port Moresby (p<0.001), and only 34.3% of 
women initiated treatment on the day of enrolment in the 
prevention of mother to child transmission programme in 
Goroka compared with 60.7% in Port Moresby (p<0.001). 
These delays translated to a higher proportion of newly 
diagnosed women receiving ART for less than 2 weeks 
before birth in Goroka (11.9%) compared with Port 
Moresby (6.1%, p=0.002).
Figure 1 Flow diagram of eligible pregnant women. ANC, 
antenatal clinic.
Figure 2 Flow diagram of eligible births. LTFU, loss to 
follow- up; PICT,Provider initiated counseling and testing.
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% (n/N) P value
Mean age (SD), n=761 25.4 (5.05) 25.7 (5.4) 25.3 (4.9) 0.33
Marital status <0.001
  Married 68.5 (518/756) 51.4 (131/255) 77.3 (387/501)
  Married- polygamist 21.6 (163/756) 40.0 (102/255) 12.2 (61/501)
  Single/no partner/boyfriend only 8.1 (61/756) 6.3 (16/255) 9.0 (45/501)
  Widow 1.9 (14/756) 2.4 (6/255) 1.6 (8/501)
Education <0.001
  No formal education 14.7 (107/730) 27.6 (70/254) 7.8 (34/476)
  Primary education only 41.0 (299/730) 42.5 (108/254) 40.1 (191/476)
  Secondary education only 36.6 (267/730) 24.8 (63/254) 42.9 (204/476)
  College/technical/vocational 6.4 (47/730) 4.7 (12/254) 7.4 (25/476)
  University 1.4 (10/730) 0.4 (1/254) 1.9 (9/476)
Employment <0.001
  Informal sector 29.3 (204/696) 38.5 (89/231) 24.7 (115/465)
  Formal employment 14.7 (102/696) 1.7 (4/231) 21.1 (98/465)
  No paid work 54.6 (380/696) 58.9 (136/231) 52.5 (244/465)
  Student 1.4 (10/696) 0.9 (2/231) 1.7 (8/465)
Region of origin <0.001
  Highlands Region 55.8 (415/744) 93.8 (240/256) 35.9 (175/488)
  Momase Region 5.1 (38/744) 4.3 (11/256) 5.5 (27/488)
  Southern Region, including NCD 36.6 (272/744) 1.2 (3/256) 55.1 (269/488)
  New Guinea Islands Region 2.6 (19/744) 0.8 (2/256) 3.5 (17/488)
Parity 0.185
  Nullipara 33.0 (250/758) 32.4 (83/256) 33.3 (167/502)
  Primipara 30.5 (231/758) 26.9 (69/256) 32.3 (162/502)
  Multipara 36.5 (277/758) 40.6 (104/256) 34.5 (173/502)
Relationship HIV status 0.105
  Concordant HIV positive 36.5 (248/679) 41.4 (106/256) 33.6 (142/423)
  Discordant HIV status 17.1 (116/679) 14.8 (38/256) 18.4 (78/423)
  Unknown status/no partner 46.4 (315/679) 43.8 (112/256) 48.0 (203/423)
HIV status disclosure <0.001
  Yes 86.8 (524/604) 95.3 (221/232) 81.5 (330/372)
Site of HIV testing <0.001
  ANC 55.4 (405/731) 49.4 (122/247) 58.5 (283/484)
  HIV/SH clinic/VCT centre 28.3 (207/731) 36.4 (90/247) 24.2 (117/484)
  Subdistrict health/aid post 2.9 (21/731) 8.5 (21/247) –
  Other area of hospital 1.1 (8/731) 2.4 (6/247) 0.04 (2/484)
  Private health clinic 0.6 (4/731) – 0.8 (4/484)
  Other 11.8 (86/731) 3.2 (8/247) 16.1 (78/484)
HIV status at ANC visit 0.02
  Known positive 45.1 (343/761) 51.0 (130/255) 42.1 (213/506)
  Newly diagnosed 54.9 (418/761) 49.0 (125/255) 57.9 (293/506)
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Infant follow-up and HIV test outcomes
There were a total of 763 live births from enrolled women 
(table 2). Almost 1 in 10 births in Goroka (9.8%) were 
non- facility births, defined as births outside a health 
facility, compared with 3.0% in Port Moresby (table 2). 
Almost all newborns (97%) in Port Moresby received ARV 
prophylaxis within 72 hours of birth, compared with only 
two- thirds of newborns in Goroka (67.5%). While there 
was no difference in the proportion of infants who had 
ever registered in a paediatric HIV programme, the rates 
of paediatric LTFU were much greater in Port Moresby 
(45.7%) compared with Goroka (23.2%, p<0.001). One 
in five infants (21.6%) were either not tested or had 
HIV DNA testing data missing, and 6.6% of tested babies 
returned a positive DNA test for HIV. Of these, only three- 
quarters were started on ART in the study period.
Maternal follow-up and factors associated with being LTFU
Of the 77 women (77 of 755, 10.2%) who were LTFU 
before they gave birth, we had sufficient programmatic 
data from 49 women (63.6%) for the multivariate analysis 
(table 3). Data were more complete for the Goroka site, 
with 72% (46 of 64) of those LTFU having sufficient data 
compared with only 23% (3 of 13) from Port Moresby 
(data not shown).
Women aged 16–20 years were almost three times more 
likely to be LTFU compared with those aged between 21 
and 30 years when adjusted for other included variables 
(adjusted OR (AOR)=2.92, 95% CI 1.16 to 7.36). Women 
in an HIV serodiscordant relationship were three times 
more likely to be LTFU (AOR=2.94, 95% CI 1.11 to 7.84) 
compared with those in an HIV seroconcordant relation-
ship, and women newly diagnosed during the current 
pregnancy were more than three times more likely to be 
LTFU before birth compared with women who already 
knew they were HIV- positive (AOR=3.50, 95% CI 1.62 to 
7.59).
Of the 113 women (113 of 757, 14.9%) who were LTFU 
before infant registration, we had sufficient program-
matic data from 61 women (54.0%) for the multivariate 
analysis (table 4). Again, completeness of data was higher 
for Goroka (64.5%) than for Port Moresby (50.0%). 
Primipara women, as compared with nullipara women, 
were significantly more likely to be LTFU before infant 
registration (AOR=3.13, 95% CI 1.44 to 6.80), as were 
women who were newly diagnosed in that current preg-
nancy (AOR=2.49, 95% CI 1.31 to 4.73).
DISCUSSION
In an attempt to quantify and explain maternal LTFU, this 
clinical audit was the first to systematically scrutinise the 
prevention of mother to child transmission programmes 
in PNG, providing much needed evidence to guide future 
programmatic efforts to improve outcomes for women 
and their children. Across two high case load and well- 
resourced sites, 1 in 10 of the women in this cohort were 
LTFU before they gave birth (n=77, 10.2%) and a further 
36 women were LTFU after birth but prior to registering 
the infant in the paediatric HIV programme (n=113, 
14.9%). More than 20% of HIV- exposed infants regis-
tered had no HIV testing data available, and of those who 
had a DNA test at 18 months of age or older more than 
6% tested positive for HIV.
More than half of the women in the cohort already knew 







% (n/N) P value
  All women 290.5 (193–409), 
n=650
327 (197–468), n=226 273 (190–384), n=424 0.005
  Known HIV- positive women 349 (235–477), n=288 364 (234–504), n=123 341 (236–451), n=165 0.219
  Newly diagnosed women 252.5 (176–360), 
n=362
279 (169–419), n=103 249 (179–341), n=259 0.154
Gestational age at enrolment, mean weeks 
(SD)
  All women (n=734) 26.1 (6.9) 25.2 (7.5) 26.6 (6.6) 0.01
  Known HIV- positive (n=332) 24.7 (7.2) 22.5 (6.9) 26.1 (7.0) <0.001
  Newly diagnosed (n=402) 27.3 (6.6) 28.0 (7.1) 26.9 (6.3) 0.14
Hepatitis B status
  Positive 12.8 (77/602) 13.7 (30/219) 12.3 (47/383) 0.61
Syphilis status
  Positive 5.2 (23/441) 7.8 (17/218) 2.7 (6/223) 0.02
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Table 2 Time on antiretroviral therapy and on prevention of mother to child transmission programmes, and delivery and 






% (n/N) P value
Mother variables (n=763 eligible pregnant women; 256 from Goroka and 507 from Port Moresby)
Known positive women on ART 0.212
  Total 99.7 (323/324) 99.1 (112/113) 100.0 (211/211)
  Ongoing treatment 91.3 (294/322) 93.7 (104/111) 90.1 (190/211)
  Recommenced in pregnancy 8.7 (28/322) 6.3 (7/111) 10.0 (21/211)
Newly diagnosed women on ART 97.8 (399/408) 92.4 (109/118) 100.0 (290/290) <0.001
Timing of ART initiation for newly diagnosed women 0.002
  ≥2 weeks before delivery 91.6 (349/381) 85.2 (86/101) 93.9 (263/280)
  <2 weeks before delivery 7.6 (29/381) 11.9 (12/101) 6.1 (17/280)
  After delivery 0.8 (3/381) 3.0 (3/101) 0.0 (0/280)
Delay between diagnosis and ART initiation for newly 
diagnosed women, median days (IQR, range)
7 days 14 days 5 days <0.001
(1–21, 0–532) (1–29, 0–532) (0–16, 0–161)
n=396 n=106 n=290
Timing of ART initiation relative to PMTCT enrolment for 
newly diagnosed women
<0.001
  Before enrolment 6.0 (24/392) 0.9 (1/108) 7.9 (23/290)
  On day of enrolment 53.5 (213/398) 34.3 (37/108) 60.7 (176/290)
  <1 week of enrolment 15.1 (60/398) 17.6 (19/108) 14.1 (41/290)
  >1 week of enrolment 25.4 (101/398) 47.2 (51/108) 17.2 (50/290)












Duration of ART before delivery, median days (IQR)
  Newly diagnosed women 71 (36–103) 57 (26–85) 75 (42–106) <0.001
  n=381 n=101 n=280
  Known positive women recommencing 108 (37–987) 167 (41–819) 104 (24–1126) 0.914
  n=49 n=15 n=34
  Known positive women on ART 887 (431–1636) 949 (500–1595) 866 (379–1690) 0.616
  n=261 n=92 n=169
LTFU before delivery <0.001
  Yes 10.2 (77/755) 25.5 (64/251) 2.6 (13/504)
  No 88.7 (670/755) 71.3 (179/251) 97.4 (491/504)
  Deceased 1.1 (8/755) 3.2 (8/251) 0.0 (0/504)
LTFU before infant registration 0.007
  Infant death 3.4 (27/757) 6.4 (16/252) 2.6 (11/505)
  LTFU 14.9 (113/757) 12.3 (31/252) 16.2 (82/505)
  In follow- up 81.5 (617/757) 81.4 (205/252) 81.6 (412/505)
Delivery details <0.001
  Supervised delivery 591/763 (77.5) 129/256 (50.4) 91.1 (462/507)
  Unsupervised delivery 40/763 (5.2) 25/256 (9.8) 3.0 (15/507)
  Data not available 132/763 (17.3) 102/256 (39.8) 5.9 (30/507)
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prevention of mother to child transmission programme 
for previous pregnancies. However, almost half the women 
enrolled were newly diagnosed with HIV in the current 
pregnancy. Consistent with findings from other settings, 
women who were newly diagnosed were more likely to be 
LTFU before they gave birth and/or before infant regis-
tration compared with women who already knew they 
were living with HIV.9 29 This further emphasises the need 
for strengthened support and counselling at the point 
of entry into the prevention of mother to child transmis-
sion programme and when prescribing lifetime ART for 
newly diagnosed women. Likewise, younger women were 
more likely to be LTFU before delivery, indicating greater 
support may need to be directed to this population. Differ-
entiated HIV support is necessary; the potential role of 
other women currently pregnant but who were already 
living with HIV and on lifetime ART should not be over-
looked. The implementation of improved programmes to 
increase HIV testing rates among women of childbearing 
age, including strengthening male involvement in ANC, 
would also help to mitigate the chances of first becoming 
aware of an HIV- positive status during pregnancy and 
improve uptake of prevention of mother to child trans-
mission services.30 It is not surprising that knowledge of 
an HIV- positive status prior to pregnancy is associated 
with increased adherence to ART.14 29 31 This audit also 
demonstrated that women who were primiparous were 
more likely to be LTFU before infant registration. While 
the factors influencing this finding remain unknown, it 
does speak to the need to target particular intervention 
approaches at the populations that they are most needed.
Although prevention of mother to child transmission 
programmes have received considerable research atten-
tion, recent systematic reviews on effective interventions 
highlight that quality evidence is still lacking to guide 
intervention design in improving uptake of ART and reten-
tion in programmes among mothers and their infants.32 33 
Success along the HIV care cascade has been achieved 
with comprehensive approaches. Using a comprehensive 
integrated approach involving point- of- care CD4 testing, 
integrated services and male community champions, a 
study in Nigeria demonstrated that mothers with access 
to comprehensively integrated system were more than 
three times likely to initiate ART and were more likely 
to be retained in care at 6 and 12 weeks post partum 
compared with mothers receiving usual care.34 More 
modest success in improving maternal enrolment in HIV 
care, maternal ART initiation and infant testing rates is 
achieved through less complex integration models, with 
many of these models of HIV care not in and of them-
selves necessarily leading to better retention in HIV care 
and prevention programmes at 6 weeks post partum.33 35 
Therefore, co- location of maternal and child HIV care 
and treatment programmes does not automatically lead 
to better HIV care and treatment outcomes,36 as our anal-
ysis shows. In our audit, LTFU rates for mothers before 
delivery were greater from the Goroka site which had 
co- located adult ART and prevention of mother to child 
transmission services. A multitude of factors previously 
reported to negatively impact retention in programmes, 
including long distances to the clinic,10 37 long wait times 
and lower educational attainment,38 are all relevant to 
women enrolled in Goroka and are all likely to contribute 
to LTFU, and these factors should be assessed and inter-
vention approaches designed to mitigate their impact. 
Again, differentiated HIV care is important in prevention 
of mother to child transmission programmes, not just 
among newly diagnosed mothers but across the country, 
as women’s sociocultural status is varied, in some respects 






% (n/N) P value
Birth outcomes (n=793) 0.001
  Live births 96.2 (763/793) 93.0 (251/270) 97.9 (512/523)
  Stillbirths 3.8 (30/793) 7.0 (19/270) 2.1 (11/523)
Proportion of infants who were given ARV prophylaxis 
within 72 hours of birth
91.3 (564/618) 67.5 (81/120) 97.0 (483/498) <0.001
Proportion of infants ever registered in a paediatric HIV 
programme
87.2 (663/760) 92.3 (229/248) 84.8 (434/512) 0.16
Proportion of infants tested for HIV at least once during 
follow- up
0.081
  Tested positive 6.6 (50/763) 6.0 (15/251) 6.8 (35/512)
  Tested negative 71.8 (548/763) 76.9 (193/251) 69.3 (355/512)
  Never tested/data not available/LTFU/infant death 21.6 (165/763) 17.1 (43/251) 23.8 (122/512)
Proportion of HIV- positive infants started on ART 74.0 (37/50) 80.0 (12/15) 71.4 (25/35) 0.527
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greatly, as does the prevalence of polygamous unions 
where there are multiple wives.
Many intervention approaches targeting individual 
behaviour have demonstrated potential in achieving 
better outcomes for mothers and infants. The use of 
phone calls and SMS (short message service)- based inter-
ventions can lead to improved maternal attendance, 
improved infant testing rates and improved retention 
at 6 weeks.33 39 Phone- based interventions have not 
been trialled in PNG, and it is questionable whether 
this approach would be acceptable considering the 
remaining stigma of being HIV- positive and the rates 
of non- disclosure in the community. In addition to this, 
the high turnover of mobile phones and numbers could 
make using this system problematic.
Previous work in other low- income settings has demon-
strated that conditional cash transfers had a positive 
impact on maternal attendance and retention,40 and 
home visits by community- based health workers have 
resulted in higher proportions of infants breast feeding 
and attending clinics within the first week of their life.41 As 
PNG moves forward to improve the prevention of mother 
to child transmission programmes across the country, this 
may well be an approach that should be piloted.
Table 3 Factors associated with enrolled mothers being lost to follow- up before they delivered their infants (n=500)
Frequency
n/N (%) Crude OR (95% CI) Adjusted OR (95% CI) P value
Site <0.001
  Port Moresby 3/303 (1.0) 1.0 1.0
  Goroka 46/197 (23.4) 30.46 (8.52 to 109.0) 39.7 (11.7 to 134.8)
Age group
  16–20 years 19/82 (23.2) 3.80 (1.97 to 7.32) 2.92 (1.16 to 7.36) 0.023
  21–30 years 25/340 (7.4) 1.0 1.0
  31–48 years 5/78 (6.4) 0.86 (0.32 to 2.33) 0.90 (0.29 to 2.73) 0.855
Marital status
  Married 24/335 (7.2) 1.0 1.0
  Married- polygamist 22/125 (17.6) 2.77 (1.48 to 5.19) 0.69 (0.31 to 1.53) 0.360
  Single/widow/no partner/boyfriend only 3/40 (7.5) 1.05 (0.30 to 3.66) 0.62 (0.14 to 2.68) 0.523
Education
  No formal education 14/79 (17.7) 1.0 1.0
  Primary education 20/203 (9.9) 0.51 (0.24 to 1.07) 0.78 (0.33 to 1.84) 0.567
  Secondary or more 15/218 (6.9) 0.34 (0.16 to 0.76) 0.66 (0.26 to 1.69) 0.389
Employment 0.400
  Formal or informal sector 19/228 (8.3) 1.0 1.0
  No paid work or student 30/272 (11.0) 1.36 (0.74 to 2.50) 0.73 (0.34 to 1.53)
Parity at enrolment
  Nullipara 26/153 (17.0) 1.0 1.0
  Primipara 10/153 (6.5) 0.34 (0.16 to 0.74) 0.74 (0.28 to 1.95) 0.539
  Multipara 13/194 (6.7) 0.35 (0.17 to 0.72) 0.58 (0.21 to 1.62) 0.301
Relationship HIV status
  Concordant HIV positive 12/212 (5.7) 1.0 1.0
  Discordant HIV status 12/94 (12.8) 2.44 (1.04 to 5.70) 2.94 (1.11 to 7.84) 0.030
  Unknown or no partner 25/194 (12.9) 2.47 (1.19 to 5.09) 1.82 (0.77 to 4.34) 0.173
HIV status disclosure
  Yes 44/444 (9.9) 1.0 1.0
  No 5/56 (8.9) 0.89 (0.34 to 2.35) 1.57 (0.41 to 5.99) 0.505
HIV status at ANC visit
  Known positive 12/273 (4.4) 1.0 1.0
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In this audit, LTFU before delivery was more likely 
among women who were living in an HIV discordant 
relationship, and addressing this factor is likely to involve 
greater male involvement in HIV care for women of child-
bearing age. Globally, there has been a focus on increasing 
male involvement in ANC, particularly in the context of 
prevention of mother to child transmission programmes. 
A number of diverse approaches have been used and 
show promising outcomes. For example, involving men 
can result in improved outcomes, including increased 
HIV testing in men, improved HIV- free survival of infants, 
increased HIV disclosure between partners and improved 
maternal adherence to care.42 In PNG male involvement 
remains limited and is constrained by many factors. These 
include persistent cultural beliefs that issues of preg-
nancy and childbirth are for women only, long waiting 
times at ANC clinics, and financial barriers, including 
loss of daily wage (or equivalent in subsistence farming 
and marketing) to attend ANC and the additional cost 
for transport. In order to improve male involvement and 
see if this approach would benefit women and children, 
substantial work needs to go into addressing the deeply 
engrained sociocultural and health service barriers.43
While the rates of LTFU found here are comparative 
with other settings with similar resources,7 what is of 
concern to the programme in PNG is how late women 
are enrolling in their pregnancies and their advanced 
HIV disease status, as evidenced by their low CD4 counts, 
Table 4 Factors associated with enrolled mothers being lost to follow- up before infant registration (n=491)
Frequency
n/N (%) Crude OR (95% CI) Adjusted OR (95% CI) P value
Site
  Port Moresby 41/299 (13.7) 1.0 1.0
  Goroka 20/192 (10.4) 0.73 (0.41 to 1.29) 0.60 (0.30 to 1.18) 0.139
Age group
  16–20 years 15/81 (18.5) 1.0 1.0
  21–30 years 42/334 (12.6) 0.63 (0.33 to 1.21) 0.63 (0.29 to 1.38) 0.246
  31–48 years 4/76 (5.3) 0.24 (0.08 to 0.80) 0.32 (0.08 to 1.22) 0.095
Marital status
  Married 35/330 (10.6) 1.0 1.0
  Married- polygamist 19/120 (15.8) 1.59 (0.87 to 2.90) 1.67 (0.83 to 3.37) 0.150
  Single/widow/no partner/boyfriend only 7/41 (17.1) 1.74 (0.71 to 4.22) 1.87 (0.70 to 5.00) 0.212
Education
  No formal education 11/76 (14.5) 1.0 1.0
  Primary education 33/202 (16.3) 1.15 (0.55 to 2.42) 0.92 (0.41 to 2.08) 0.849
  Secondary or more 17/213 (8.0) 0.51 (0.23 to 1.16) 0.42 (0.17 to 1.02) 0.056
Employment
  Formal or informal sector 22/223 (9.9) 1.0 1.0
  No paid work or student 39/268 (14.6) 1.56 (0.89 to 2.72) 1.40 (0.76 to 2.57) 0.277
Parity at enrolment
  Nullipara 19/150 (12.7) 1.0 1.0
  Primipara 26/148 (17.6) 1.47 (0.77 to 2.80) 3.13 (1.44 to 6.80) 0.004
  Multipara 16/193 (8.3) 0.62 (0.31 to 1.26) 1.48 (0.61 to 3.57) 0.384
Relationship HIV status
  Concordant HIV positive 17/213 (8.0) 1.0 1.0
  Discordant HIV status 12/94 (12.8) 1.69 (0.77 to 3.70) 1.70 (0.74 to 3.91) 0.215
  Unknown or no partner 32/184 (17.4) 2.43 (1.29 to 4.57) 1.47 (0.69 to 3.16) 0.318
HIV status disclosure
  Yes 47/436 (10.8) 1.0 1.0
  No 14/55 (25.5) 2.83 (1.42 to 5.61) 1.64 (0.70 to 3.80) 0.252
Knowledge of HIV status
  Known positive 21/269 (7.8) 1.0 1.0
  Newly diagnosed 40/222 (18.0) 2.60 (1.47 to 4.59) 2.49 (1.31 to 4.73) 0.005
G
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particularly for newly diagnosed women. At the time 
of this work and today in PNG, pregnant women with 
HIV are not offered HIV viral load testing; they are not 
a population eligible for such testing in the approved 
testing algorithm, and therefore we cannot examine 
what, if any, HIV viral load plays in LTFU. Further to this 
is the recorded delays between diagnosis and treatment 
initiation, resulting in less time on ART prior to birth to 
sufficiently reduce the viral load and reduce the risk of 
mother to child transmission. These delays are important 
to highlight as they offer obvious targets for programme 
improvement to reduce viral load. Yet the other issue is 
real: pregnant women who initiate treatment the day that 
they are diagnosed have been shown to be significantly 
less adherent than newly diagnosed pregnant women 
whose treatment is delayed.44
Essential to reducing and eliminating paediatric infec-
tions, the coverage of timely ARV prophylaxis for infants 
exposed to HIV must be resolved. In the period of this 
study, one- third (39 of 120, 32.5%) of infants in Goroka 
were not administered ARV prophylaxis within 72 hours of 
birth. This figure may, in part, be due to the high number 
of non- facility- based births, where mothers may have 
been unable or unwilling to present to the prevention of 
mother to child transmission clinic with their newborns 
within 72 hours of birth. Improving counselling around 
the importance of this prophylaxis, decentralising ARV 
prophylaxis to lower health centres where women give 
birth, encouraging supervised and facility- based births, 
and providing the necessary financial and logistic means 
to do so are interventions that warrant investigation.
Not only was the known HIV positivity rate among 
infants exposed to HIV greater than it should be with 
an effective prevention of mother to child transmission 
programme, HIV DNA testing rates were also subop-
timal, with more than 20% of infants having no evidence 
of an HIV DNA test. These figures do not speak to effec-
tive programme implementation and provide evidence 
of high LTFU and failure of the health system to reach 
HIV- exposed infants with prevention of mother to child 
transmission services. These key infant measures high-
light the real and urgent need for programmes to reduce 
infant LTFU to be adequately resourced and processes 
facilitating early infant diagnosis to be strengthened as a 
matter of urgency. Since this audit, no new programmes 
or resources have been put towards the national preven-
tion of mother to child transmission programme, so these 
issues are likely to remain ever present, as highlighted 
and reinforced at the PNG HIV summit that called for 
a revitalisation amid expansion of the prevention of 
mother to child transmission programme to reduce 
transmission.45 Noting that, in 2017, 150 children were 
diagnosed with HIV, a figure that doubled to 300 in 2018, 
the report notes that ‘new- born children in PNG are 
at dangerously increased risk of acquiring HIV’. Thus, 
although this audit reflects years prior to this statement, 
the report shows that the findings and issues raised by 
the audit are current.
Limitations
In retrospective studies using routine data there are often 
data challenges, with missing data precluding the inclu-
sion of some women who were LTFU in the multivariate 
analysis. We were challenged by the paper- based system 
for this reason as well as the use of non- standardised 
forms, both of which resulted in incomplete and inconsis-
tent recording of patients’ medical histories. Paper- based 
systems and the requirement to manually identify and 
link mother and infant records resulted in a significant 
delay to data collection and therefore strategic infor-
mation to inform practice and policy. A computerised 
database that can link women in prevention of mother 
to child programmes to their children in paediatric HIV 
services and their records in adult HIV services would 
be a significant advancement for monitoring individual 
patient outcomes as well as national data on programme 
performance. The retrospective analysis also precluded 
us from gathering any further information from women 
who were LTFU on what barriers to remaining in care 
they experienced. These qualitative enquiries would 
further inform programme strengthening.
CONCLUSIONS
There is an urgent need for PNG to invest in its preven-
tion of mother to child transmission programmes. In its 
current state, as we have shown, an unacceptably high 
proportion of women and their infants are LTFU, with 
other poor indicators including delays in ART initia-
tion, number of stillbirths, delayed infant prophylaxis, 
high transmission rates and suboptimal testing rates. 
Women within the programme need to be more strongly 
supported to prevent LTFU and improve outcomes. With 
the current programme, the goal of the elimination of 
prevention of mother to child transmission will remain 
elusive and the health and well- being of women living 
with HIV and their children suboptimal.
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